A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study
Public ClinicalTrials.gov record NCT01711814. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Open-Label, Noncomparative, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the long-term safety and efficacy of ASP015K in subjects with Rheumatoid Arthritis (RA) who have completed a preceding Phase 2 ASP015K RA study.
Study identification
- NCT ID
- NCT01711814
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 611 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 26, 2012 (Actual)
- Primary completion
- Mar 25, 2016 (Actual)
- Completion
- Mar 25, 2016 (Actual)
- Last update posted
- Oct 21, 2024
2012 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US3218 | Birmingham | Alabama | 35216 | — |
| Site US828 | La Jolla | California | 92093-0943 | — |
| Site US3227 | Palm Desert | California | 92260 | — |
| Site US219 | Palo Alto | California | 94304 | — |
| Site US3332 | Santa Maria | California | 93454 | — |
| Site US3331 | Colorado Springs | Colorado | 80920 | — |
| Site US1894 | Jacksonville | Florida | 32216 | — |
| Site US3232 | Orlando | Florida | 32804 | — |
| Site US702 | Morton Grove | Illinois | 60053 | — |
| Site US3226 | Vernon Hills | Illinois | 60061 | — |
| Site US3329 | Elizabethtown | Kentucky | 42701 | — |
| Site US291 | Wheaton | Maryland | 20902 | — |
| Site US3298 | Hickory | North Carolina | 28602 | — |
| Site US3300 | Oklahoma City | Oklahoma | 73103 | — |
| Site US345 | Duncansville | Pennsylvania | 16635 | — |
| Site US3304 | Wyomissing | Pennsylvania | 19610 | — |
| Site US3306 | Knoxville | Tennessee | 37909 | — |
| Site US3319 | Austin | Texas | 78705 | — |
| Site US3327 | Chesapeake | Virginia | 23320 | — |
| Site US3320 | Clarksburg | West Virginia | 26301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01711814, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 21, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01711814 live on ClinicalTrials.gov.